2023
DOI: 10.3389/fendo.2023.1089190
|View full text |Cite
|
Sign up to set email alerts
|

Thyroxine changes in COVID-19 pandemic: A systematic review and meta-analysis

Abstract: ObjectiveCOVID-19 infection may affect thyroid function. However, changes in thyroid function in COVID-19 patients have not been well described. This systematic review and meta-analysis assess thyroxine levels in COVID-19 patients, compared with non-COVID-19 pneumonia and healthy cohorts during the COVID-19 epidemic.MethodsA search was performed in English and Chinese databases from inception to August 1, 2022. The primary analysis assessed thyroid function in COVID-19 patients, comparing non-COVID-19 pneumoni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 73 publications
0
1
0
Order By: Relevance
“…Recently, NTIS has been reported to complicate the course of the diseases in patients admitted to the ICU because of COVID-19 [431][432][433][434]. The relationship between thyroid function and COVID-19 was recently examined in a systematic review of studies performed on a total of more than 5800 patients [435]. This systematic review confirmed that thyroid hormone levels, especially FT3 levels, were reduced in patients with COVID-19, compared to the healthy cohort, and this alteration was more evident in severe COVID-19 patients with pneumonia compared to those without pneumonia, indicating that decreased FT3 levels have clinical significance for the prognosis of this condition.…”
Section: Frailty and The Low T3 Syndromementioning
confidence: 99%
“…Recently, NTIS has been reported to complicate the course of the diseases in patients admitted to the ICU because of COVID-19 [431][432][433][434]. The relationship between thyroid function and COVID-19 was recently examined in a systematic review of studies performed on a total of more than 5800 patients [435]. This systematic review confirmed that thyroid hormone levels, especially FT3 levels, were reduced in patients with COVID-19, compared to the healthy cohort, and this alteration was more evident in severe COVID-19 patients with pneumonia compared to those without pneumonia, indicating that decreased FT3 levels have clinical significance for the prognosis of this condition.…”
Section: Frailty and The Low T3 Syndromementioning
confidence: 99%